Should bisphosphonates be the treatment of choice for metastatic bone disease?

被引：27
作者：
Coleman, RE [1 ]
机构：
[1] Weston Pk Hosp, Canc Res Ctr, Dept Clin Oncol, Sheffield, S Yorkshire, England
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期
关键词：
D O I：
10.1053/sonc.2001.25427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 41
页数：7
相关论文
共 35 条
[1]  
[Anonymous], BISPHOSPHONATES BONE
[2]   EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].
BELCH, AR ;
BERGSAGEL, DE ;
WILSON, K ;
OREILLY, S ;
WILSON, J ;
SUTTON, D ;
PATER, J ;
JOHNSTON, D ;
ZEE, B .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402
[3]  
Berenson J., 2000, Breast Cancer Research and Treatment, V64, P32
[4]  
BERENSON J, 2000, BREAST CANC RES TREA, V64, P1
[5]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[6]   Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, M ;
Blacklock, H ;
Bell, R ;
Simeone, JF ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602
[7]  
BERENSON JR, IN PRESS CANCER
[8]  
Blamey R, 1999, EUR J SURG ONCOL, V25, P3
[9]   A dose-finding study of zoledronate in hypercalcemic cancer patients [J].
Body, JJ ;
Lortholary, A ;
Romieu, G ;
Vigneron, AM ;
Ford, J .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (09) :1557-1561
[10]  
BODY JJ, 1999, P AN M AM SOC CLIN, V18, pA575
1234